The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,274.00
Bid: 3,256.00
Ask: 3,260.00
Change: 20.00 (0.61%)
Spread: 4.00 (0.123%)
Open: 3,230.00
High: 3,302.00
Low: 3,230.00
Prev. Close: 3,254.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Mar 2024 12:33

RNS Number : 3726G
Spectris PLC
11 March 2024

Spectris plc: Director/PDMR Shareholding

This notification made under Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

On 8 March 2024, Spectris plc (the "Company") was notified that on the same day, Derek Harding, Chief Financial Officer and Andrew Heath, Chief Executive, acquired 10,392 and 13,055 ordinary shares of 5p each ("Ordinary Shares") in the Company respectively following the exercise of options granted under the terms of the Performance Share Plan ("PSP") on 7 March 2019.

Of the 10,392 Ordinary Shares acquired by Mr Harding, 5,000 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £33.452 and the remaining 5,392 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

Of the 13,055 Ordinary Shares acquired by Mr Heath, 6,164 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £33.465 and the remaining 6,891 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

The forms for this transaction, as required under MAR, follows:

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Derek Harding, Chief Financial Officer

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

(i) Exercise of options over 10,392 Ordinary Shares under the terms of the PSP granted on 7 March 2019.

(ii) Subsequent sale of 5,000 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise.

(iii) Transfer of remining 5,392 Ordinary Shares into a nominee account on Mr Harding's behalf.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(i) Acquisition

£0.05

£0.00

£26.69

8,981 (Share Award granted as a nominal cost option under the terms of the PSP)

1,127 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)

284 (Share Award granted as a tax-advantaged market value option under the terms of the PSP)

(ii) Sale

£33.452

5,000

(iii) Transfer

£nil

5,392

d)

Aggregated information

(i) Acquisition

Price per share

£0.7726

Volume

10,392

Price

£8,029.01

(ii) Sale

Price per share

£33.452

Volume

5,000

Price

£167,260.00

(iii) Transfer

Price per share

£0.00

Volume

5,392

Price

£0.00

e)

Date of the transaction

8 March 2024

f)

Place of the transaction

Outside of a trading venue

1

Details of the persons discharging managerial responsibilities

a)

Name(s)

Andrew Heath, Chief Executive

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectris plc

b)

LEI

213800Z4CO2CZO3M3T10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0003308607

b)

Nature of the transaction

(i) Exercise of options over 13,055 Ordinary Shares under the terms of the PSP granted on 7 March 2019.

(ii) Subsequent sale of 6,164 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise.

(iii) Transfer of remining 6,891 Ordinary Shares into a nominee account on Mr Heath's behalf.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(i) Acquisition

£0.05

£0.00

11,608 (Share Award granted as a nominal cost option under the terms of the PSP)

1,447 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)

(ii) Sale

£33.465

6,164

(iii) Transfer

£nil

6,891

d)

Aggregated information

(i) Acquisition

Price per share

£0.04446

Volume

13,055

Price

£580.40

(ii) Sale

Price per share

£33.465

Volume

6,164

Price

£206,278.26

(iii) Transfer

Price per share

£0.00

Volume (Shares Acquired)

6,891

Price (Shares Acquired)

£0.00

e)

Date of the transaction

8 March 2024

f)

Place of the transaction

Outside of a trading venue

Name of contact and telephone number for queries:

Guy Holden

Group Reward and Share Plan Manager

07585 403 180

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Date: 11 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGPUPWWUPCGPG
Date   Source Headline
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares
23rd Feb 20246:03 pmRNSTransaction in Own Shares
22nd Feb 20245:34 pmRNSTransaction in Own Shares
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:41 pmRNSTransaction in Own Shares
19th Feb 20245:38 pmRNSTransaction in Own Shares
16th Feb 20245:58 pmRNSTransaction in Own Shares
15th Feb 20246:05 pmRNSTransaction in Own Shares
14th Feb 20245:26 pmRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.